Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
LONDON and PHOENIX, April10, 2025(GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the Company that he has recently purchased an additional 38,000 ACUT shares in the open market. This brings his total holding to 4,910,759 shares. About AccuStem AccuStem is a clinical stage diagnostics company dedicated to...
Nasdaq GlobeNewswire
10/04/2025
The Helsinki Court of Appeal sentenced a member of Orion's Board of Directors to…
ORION CORPORATIONSTOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 10 APRIL 2025 at 13.15 EEST The Helsinki Court of Appeal sentenced a member of Orion's Board of Directors to a fine for a securities market information offence It has come to the attention of Orion Corporation that the Helsinki Court of Appeal has sentenced Ari Lehtoranta, a member of Orion's Board of Directors, to a fine for a securities market information...
Nasdaq GlobeNewswire
10/04/2025
Curium strengthens its PET manufacturing capacity and expands European footprint…
The acquisition of Nucleis will: Enhance Curium's PET manufacturing capacity and radiopharmaceutical distribution network of 32 PET sites in Western EuropeImprove reliability and accessibility of life-saving PET diagnostics for patients in Benelux and GermanyExpand CDMO capabilities to support the development of innovative PET tracers in oncology, neurology, and cardiologyPARIS, April10, 2025(GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it...
Nasdaq GlobeNewswire
10/04/2025
Isotopia Announces the UK Launch of Isoprotrace®, an Innovative Diagnostic…
This milestone underscores Isotopia's profound commitment to expanding access to high-quality diagnostic tools and improving patient care globally. Isoprotrace® is an innovative PSMA-11 (Gozetotide) radiolabelling kit designed to enhance the precision of prostate cancer imaging. The ready-to-use, multi-dose kit facilitates the efficient preparation of Gallium-68 Gozetotide solution for intravenous injection, equipping healthcare providers with a critical tool for diagnosing prostate...
PR Newswire
10/04/2025
Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic…
DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME)Over 800 patients randomized in DIAMOND-1 or DIAMOND-2 Phase 3 trials at an industry-leading record speed across 119 sites worldwide primarily in the US; topline data readout expected in Q2 2026 with NDA submission to followCompany to provide an update on the DIAMOND program and its innovative late-stage pipeline at the upcoming in-person and virtual...
Nasdaq GlobeNewswire
10/04/2025
The Ulike Air 10 Revolutionises Self-Care and Delivers Salon-Quality Results…
The Problem with Traditional Hair RemovalShaving is quick but short-lived, often causing irritation, ingrown hairs, and daily upkeep. Waxing lasts longer but is painful, expensive, and can leave skin sensitive. Both require constant maintenance — adding time and cost. The Problem with Traditional Hair RemovalShaving is quick but short-lived, often causing irritation, ingrown hairs, and daily upkeep. Waxing lasts longer but is painful, expensive, and can leave skin sensitive. Both require...
PR Newswire
10/04/2025
Orexo announces positive data for powder-based intranasal vaccine formulated…
The proof-of-concept study was conducted in rats where Abera's influenza vaccine candidate was administered intranasally, either formulated as a liquid nasal solution or as an intranasal powder using Orexo's AmorphOX technology. Both formulations induced strong systemic antibody response in serum (IgG) as well as locally in the nose and lungs (IgA). No difference in immune response was seen between the liquid nasal solution and the intranasal powder. The proof-of-concept study was conducted…
PR Newswire
10/04/2025
SKF to publish Q1 report on 25 April
To join the webcast, please login at least 10 minutes before the start using the below link or phone numbers: To join the webcast, please login at least 10 minutes before the start using the below link or phone numbers: Link to web event:https://www.investis-live.com/skf/67e26af6eeffcd000f59a93e/mpwrt Sweden : +46 8 5051 0031 UK / International: +44 207 107 0613 All information regarding the results will be made available on the Group's IR website:...
PR Newswire
10/04/2025
Implantica announces a newly published real-world study from Germany reinforcing…
Dr. med. Elshafei says, "I have treated thousands of patients with reflux and actively participated in the evolution of new technologies over the years. This is the first time I have witnessed a radically different approach to treating reflux disease without compressing the food passageway and restoring the natural anatomy of not just the sphincter muscle but also the complete gastric anatomy and physiology. This is what really drives such excellent outcomes with the RefluxStop…
PR Newswire
10/04/2025
Fagron to present its upgraded growth strategy and mid-term financial targets at…
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 10 April 2025 – 7AM CET Fagron to present its upgraded growth strategy and mid-term financial targets at its Capital Markets Day 2025 Fagron, the leading global player in pharmaceutical compounding will host its Capital Markets Day 2025 today from 2PM CET. The event will include presentations from CEO Rafael Padilla and CFO Karin de Jong, as well as regional and functional leaders. The Company will provide an update on...
Nasdaq GlobeNewswire
10/04/2025
Record first-quarter revenue of €239 million, reflecting 14% topline growth
Regulated information - inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 10 April 2025 – 7:00 AM CET Record first-quarter revenue of €239 million, reflecting 14% topline growthFagron, the leading global player in pharmaceutical compounding, today publishes its quarterly results for the period ending 31 March 2025. Key Highlights Revenue maintained its strong growth momentum, increasing 14.1% on reported basis to €238.7 million (15.2% at CER), with all regions...
Nasdaq GlobeNewswire
10/04/2025
Merkel Cell Carcinoma Market to Grow Rapidly at a CAGR of 8.7% During the Study…
Key Takeaways from the Merkel Cell Carcinoma Market Report Key Takeaways from the Merkel Cell Carcinoma Market Report Discover which therapies are expected to grab the majorMerkelcell carcinoma market share @ Merkel Cell Carcinoma Market Report Merkel Cell Carcinoma Overview Merkelcell carcinoma (MCC) is a rare and aggressive skin cancer that originates fromMerkelcells, which are neuroendocrine cells involved in touch sensation. While its exact causes are not...
PR Newswire
09/04/2025
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial…
Attachment Notification of managers' transaction - Riad Sherif - April 2025 RSU vest
Nasdaq GlobeNewswire
09/04/2025
Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and…
Cosmos Health Inc.("Cosmos Health" or the “Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that its wholly owned subsidiary, Cana Laboratories (“Cana”), has completed the latest upgrades to its manufacturing capabilities and capacity, and has...
Nasdaq GlobeNewswire
09/04/2025
Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic…
COPENHAGEN, Denmark, April 9, 2025– Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following results: The Annual Report for 2024 was adopted. The Board of Directors' proposal to transfer the Company's result to 2025 was also adopted.The Remuneration Report for 2024 was not approved. It is noted that this was an indicative vote, and that the decision will not entail consequences on the reported remuneration. The Board of Directors will discuss the...
Nasdaq GlobeNewswire
09/04/2025
Casino Group: Availability of preparatory documents for the AGM of 30 April 2025
CASINO, GUICHARD-PERRACHONA Frenchsociété anonyme(joint-stock company) with share capital of €4,009,397.13 Registered office: 1, Cours Antoine Guichard 42000 Saint-Etienne, France Registered with the Saint-Etienne Trade and Companies Registry Availability of information related to the Ordinary and Extraordinary Annual General Meeting of 30 APRIL 2025 CASINO, GUICHARD-PERRACHON's shareholders are invited to participate in the Ordinary and Extraordinary Shareholders' Meeting which...
Nasdaq GlobeNewswire
09/04/2025
Virbac : Declaration of the number of shares and voting rights 03/2025
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers)Quotation place: Euronext Paris Compartiment A ISIN code: FR0000031577DateTotal number of shares representing the share capitalTotal number of voting rightsMarch, 31 20258 390 660Gross total of voting rights :...
Nasdaq GlobeNewswire
09/04/2025
US Medical Aesthetics Market worth US$16.38 billion by 2030 with 13.6% CAGR |…
Browse in-depth TOC on "US Medical Aesthetics Market" Browse in-depth TOC on "US Medical Aesthetics Market" 120 - Tables 30 - Figures By Based on Facial aesthetics products segment,In the US, the medical aesthetics market is classified based on product into facial aesthetic products, body contouring devices, cosmetic implants, physical dispensed cosmeceuticals and skin lighteners, skin aesthetic devices, physician-dispensed eyelash products, hair removal devices, tattoo...
PR Newswire
09/04/2025
Financial Release: JOY GROUP Achieves 36% Revenue Growth to Reach US$483M in…
In haircare category, JOY GROUP has taken over full operations of René Furterer, a prestige French haircare brand founded in 1957, in China since January 1, 2024. The brand achieved strong growth in the first year of operation, most notably a 72% revenue surge in the second half, backed by JOY's local insights and market execution. In haircare category, JOY GROUP has taken over full operations of René Furterer, a prestige French haircare brand founded in 1957, inChinasinceJanuary 1, 2024...
PR Newswire
09/04/2025
Air Conditioners Market to Reach $276.7 Billion by 2032, Growing at a CAGR of…
Browse in-depth scope of the Air Conditioners Market Report:362 – Tables46 – Figures300 – Pages Browse in-depth scope of the Air Conditioners Market Report: 362 – Tables 46 – Figures 300 – Pages For more comprehensive insights, download the FREE report sample: https://www.meticulousresearch.com/download-sample-report/cp_id=5384 KEY MARKET DRIVERS AND TRENDS The air conditioners market is experiencing robust growth due to the rising global...
PR Newswire
09/04/2025
Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR…
The company announced today that it will showcase a conceptual video introducing the CURECA™ system at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global 2025), held April 11-15 in Vienna, Austria. The video will outline the system's design goals and envisioned workflow. A physical demonstration of the system is expected to take place in July 2025 at the Association for Diagnostics & Laboratory Medicine (ADLM 2025) in Chicago. The company announced today…
PR Newswire
09/04/2025
Oxolife's CEO Agnès Arbat receives prestigious EU Women Innovators Prize
Agnès Arbat, Chief Executive Officer, Oxolife, said: "I am deeply honoured to receive this award among such an inspiring group of women innovators who are pushing boundaries and making a real impact. At Oxolife we are advancing our lead candidate to improve fertility, an area that is very close to my heart, so this recognition is especially rewarding. I am incredibly grateful to my dedicated team at Oxolife, as well as our advisors, investors, and supporters. This achievement is a testament…
PR Newswire
09/04/2025
Mars Veterinary Health Underscores Long-Term Commitment to Research & Innovation…
Global leader in peer-reviewed veterinary research highlights progress in advancing veterinary science and clinical excellence through inaugural science report launch Science Impact Report: Pets, Purpose & Progress: Synergizing Research and Clinical Excellence, highlighting the company's extensive global contributions to veterinary science in 2024.The Science Impact Report reflects Mars Veterinary Health's longstanding commitment to advancing evidence-based medicine that helps ensure...
Nasdaq GlobeNewswire
09/04/2025
Corti Launches Medical Dictation API, Democratizing Access to Premium Dictation…
State-of-the-art speech recognition like Whisper struggles with medical transcription, showing word error rates of up to 40 percent on medical dictation. Healthcare language requires specialized AI built with a deeply nuanced understanding of medical terminology. State-of-the-art speech recognition like Whisper struggles with medical transcription, showing word error rates of up to 40 percent on medical dictation. Healthcare language requires specialized AI built with a deeply nuanced...
PR Newswire
09/04/2025
Altri Comunicati
